..Ascertainment of patients with PPMS from clinic-based populations can facilitate a powerful comparison of age at progression onset between secondary progressive MS (SPMS) and PPMS but may introduce unclear biases...

Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica